Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Outcomes Following Curative Hepatectomy for Hepatocellular Carcinoma in Patients With and Without Metabolic-Associated Fatty Liver Disease: Insights from a Western Cohort Study

  • By

  • Michele Molinari

  • Vrishketan Sethi

  • Christof Kaltenmeier

  • Abiha Abdullah

  • Berkay Demirors

  • Matthew Yu-Sheng Lin

  • Jason Mial-Anthony

  • Dooman Arefan

  • Shandong Wu

  • Christopher Buros

  • Hao Liu

  • Charbel Elias

  • Marta Minervini

  • Samer Tohme

  • Xingyu Zhang

  • David Geller

  • Alessandro Furlan

  • July 16, 2026

Share

Original Source(s)

Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study

  • by Michele Molinari, Vrishketan Sethi, Christof Kaltenmeier, Abiha Abdullah, Berkay Demirors, Matthew Yu-Sheng Lin, Jason Mial-Anthony, Dooman Arefan, Shandong Wu, Christopher Buros, Hao Liu, Charbel Elias, Marta Minervini, Samer Tohme, Xingyu Zhang, David Geller, Alessandro Furlan

  • July 16, 2026

Related Content

The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Adaptive Radiation Boost for Rectal Cancer (ARBOR)

The goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer.

  • by

  • September 4, 2026

  • 3 min